| Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors SA Moghadasi, E Heilmann, AM Khalil, C Nnabuife, FL Kearns, C Ye, ... Science Advances 9 (13), eade8778, 2023 | 127 | 2023 |
| SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376 E Heilmann, F Costacurta, SA Moghadasi, C Ye, M Pavan, D Bassani, ... Science translational medicine 15 (678), eabq7360, 2022 | 95 | 2022 |
| High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl L Knabl, T Mitra, J Kimpel, A Rössler, A Volland, A Walser, H Ulmer, ... Communications medicine 1 (1), 4, 2021 | 68 | 2021 |
| Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants A Volland, M Lohmüller, E Heilmann, J Kimpel, S Herzog, D von Laer PLoS Pathogens 17 (10), e1009996, 2021 | 21 | 2021 |
| A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition E Heilmann, F Costacurta, S Geley, SA Mogadashi, A Volland, B Rupp, ... Communications Biology 5 (1), 391, 2022 | 16 | 2022 |
| SARS-CoV-2 3CLpro mutations confer resistance to Paxlovid (nirmatrelvir/ritonavir) in a VSV-based, non-gain-of-function system E Heilmann, F Costacurta, A Volland, D von Laer BioRxiv, 2022.07. 02.495455, 2022 | 13 | 2022 |
| Chemogenetic ON and OFF switches for RNA virus replication E Heilmann, J Kimpel, B Hofer, A Rössler, I Blaas, L Egerer, T Nolden, ... Nature communications 12 (1), 1362, 2021 | 12 | 2021 |
| The methyltransferase region of vesicular stomatitis virus L polymerase is a target site for functional intramolecular insertion E Heilmann, J Kimpel, S Geley, A Naschberger, C Urbiola, T Nolden, ... Viruses 11 (11), 989, 2019 | 12 | 2019 |
| Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. bio Rxiv: 2022.08. 07.503099 SA Moghadasi, E Heilmann, AM Khalil, C Nnabuife, FL Kearns, C Ye, ... There is no corresponding record for this reference, 2022 | 8 | 2022 |
| SARS-CoV-2 3CL (pro) mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376. Sci. Transl. Med. 15, eabq7360 E Heilmann, F Costacurta, SA Moghadasi, C Ye, M Pavan, D Bassani, ... | 8 | 2022 |
| Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. bioRxiv (2022) SA Moghadasi, E Heilmann, A Khalil, C Nnabuife, FL Kearns, C Ye, ... Google Scholar, 0 | 5 | |
| A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system F Costacurta, A Dodaro, D Bante, H Schöppe, JY Peng, B Sprenger, X He, ... PLoS Pathogens 20 (9), e1012522, 2024 | 4 | 2024 |
| Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir L Krismer, H Schöppe, S Rauch, D Bante, B Sprenger, A Naschberger, ... npj Viruses 2 (1), 23, 2024 | 1 | 2024 |
| Using Vesicular Stomatitis Virus as a Platform for Directed Protease Evolution F Costacurta, S Rauch, D von Laer, E Heilmann Current protocols 4 (12), e70074, 2024 | | 2024 |
| Vesicular stomatitis virus as a platform for protease activity measurements S Rauch, F Costacurta, D von Laer, E Heilmann Current Protocols 4 (11), e70062, 2024 | | 2024 |
| Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system S Rauch, F Costacurta, H Schöppe, JY Peng, D Bante, EE Erisoez, ... Antiviral Research 231, 105969, 2024 | | 2024 |
| Novel Mechanism to Control RNA Virus Replication and Gene Expression MD Holm-von Laer, E Heilmann, J Kimpel, G Wollmann, L Egerer, B Hofer US Patent App. 17/620,386, 2022 | | 2022 |
| Spezialkost für DysphagiepatientInnen A Karner, M Kandlbauer, I Popek, C Rothner, A Rössler, S Hoffmann, ... Aktuelle Ernährungsmedizin 33 (03), A8_1, 2008 | | 2008 |
| Spezialkost für DysphagiepatientInnen A Karner, M Kandlbauer, I Popek, C Rothner, A Rössler, S Hoffmann, ... Aktuelle Ernährungsmedizin 32 (03), P4_3, 2007 | | 2007 |
